InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Browse the complete record of transactions filed by Birx Deborah, Director. Officer active across 3 companies, notably Innoviva, Inc.. Cumulatively, 7 reports have been logged. Activity tracked since 14 May 2021. The latest transaction was filed on 10 July 2024 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
7 of 7 declarations
Deborah Birx is a Board Member at Innoviva, Inc., a company specializing in drug development. As a board member, she contributes to the governance of the company and to strategic decision-making.